News Updates from the 83rd Scientific Sessions
Carmella Evans-Molina, MD, PhD, this year’s Outstanding Scientific Achievement Award winner, was first interested in understanding the beta-cell pathways that drive the transition from normoglycemia to dysglycemia to diabetes. Now she is focusing on ways to leverage beta-cell stress to inform type 1 diabetes biomarker development.
Read more
DKD may look the same clinically in type 1 diabetes and type 2 diabetes, but research suggests there are differences that could influence risk, progression, and treatment for patients with each type of diabetes. “We are looking into molecular pathways and planning direct comparisons between type 1 diabetes and type 2 diabetes to find altered mechanisms,” said Viji Nair, PhD, MS. Read more
Factors including food insecurity, community, and economic disadvantage play integral roles in the development and care of diabetes, according to four experts who took a closer look at social determinants of health and diabetes. Felicia Hill-Briggs, PhD, ABPP, provided an overview of SDOH in the development of diabetes. She was the chair of the committee that wrote the scientific review of SDOH for Diabetes Care. Read more
Nutrient-stimulated hormones have changed the landscape of weight loss recently, and four scientists, including Jonathan Campbell, PhD, presented information about several types of combinations of these therapies that have and are being tested in trials. Read more
In a Monday morning symposium, three scientists spotlighted major advancements in diabetes from the past year, from new guidelines and statements to a bionic pancreas and anti-obesity drugs. John B. Buse, MD, PhD, reported that health equity issues remain the biggest challenge in advancing diabetes treatment and prevention. Read more
Nutrition plays a significant role in a patient’s diabetes management, but there is no universal approach to incorporating a healthy diet. Ka Hei Karen Lau, MS, RDN, LDN, CDCES, and other specialists explored various nutrition programs, such as providing food benefits to those without access to food, offering education on food choices, and addressing weight stigma. Read more
Presenter Michael R. Rickels, MD, MS, shares insight into a debate that begins Monday at 3:15 p.m. PT in Room 30. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.
Read More
A symposium beginning Monday at 3:15 p.m. PT in Room 28 will feature panel of diabetes care experts, including Christine Limonte, MD, discussing what is happening in the world of antihyperglycemic and antihypertensive agents—and beyond—as diabetic kidney disease continues to be a prevalent complication from diabetes. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.
Read More
Throughout the 83rd Scientific Sessions, attendees have been writing down the reasons why they are involved in diabetes research and care. Don't forget to add your story to the board near the registration desk in the Sails Pavilion on the upper level of the convention center.
In a symposium beginning Monday at 3:15 p.m. PT in Ballroom 6A-B, principal Investigator John Kirwan, MSc, PhD, will present ARMMS-T2D study results comparing surgery versus medical and lifestyle intervention in patients with type 2 diabetes, as well as long-term effects post-surgery. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.
Read More
Presenters Christine P. Limonte, MD, and Ashish Verma, MBBS, share insight into a symposium that begins Monday at 3:15 p.m. PT in Room 28. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.
Read More
During a symposium beginning Monday at 3:15 p.m. PT in Ballroom 20A-C, Risa Wolf, MD, will share data that suggests GLP-1 receptor agonists can worsen diabetic retinopathy. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.
Read More
Rodica Busui, MD, PhD, discusses her role as ADA President of Medicine & Science. Dr. Busui is also the recipient of the 2023 Banting Medal for Leadership and Service, which recognizes her outstanding leadership and service to the American Diabetes Association®.
A symposium beginning Monday at 1:30 p.m. PT in Ballroom 20A-C will feature Arun J. Sanyal, MD, and other investigators sharing new data on retatrutide and its effects on obesity, type 2 diabetes, and nonalcoholic steatohepatitis. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.
Read More
During a panel discussion beginning Monday at 1:30 p.m. PT in Room 28, nephrology and diabetes experts, including Titilayo O. Ilori, MD, MSc, will discuss the impact of race, ethnicity, and underrepresentation of vulnerable populations in clinical trials in relation to diabetes and kidney disease. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.
Read More
In a symposium beginning Monday at 1:30 p.m. PT in Room 30, investigators including Neha Pagidipati, MD, MPH, will review the results of the COORDINATE-Diabetes trial. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.
Read More
Presenter Elizabeth J. Rideout, PhD, shares insight into a symposium that begins Monday at 1:30 p.m. PT in Ballroom 6A-B. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.
Read More
Carmella Evans-Molina, MD, PhD, discusses the work that led her to be named the recipient of the ADA's 2023 Outstanding Scientific Achievement Award. She delivered an award lecture Monday morning, and a recording can be viewed on the virtual platform at ADA2023.org.
During a professional development session beginning Monday at 11:30 a.m. PT in Ballroom 20A-C, Marie Brown, MD, of the American Medical Association will explain how to effectively address clinical burnout at an organizational level using real-world examples of success centered on practice efficiency. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.
Read More
Presenter Joanna Mitri, MD, MS, shares insight into a professional interest group discussion that begins Monday at 11:30 a.m. PT in Ballroom 6A-B. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.
Read MoreScientific Sessions Meeting Planning Committee Chair Alice Y.Y. Cheng, MD, FRCPC, previews noteworthy sessions on Monday’s schedule, plus Ania M. Jastreboff, MD, PhD, and Jennifer B. Green, MD, offer sneak peeks at Monday afternoon symposia that will feature results from clinical trials.
Visit the Shop Diabetes Store in the Sails Pavilion in the upper level of the convention center until 4:30 p.m. PT Monday to purchase official American Diabetes Association® apparel, gifts, and professional books. Each sale supports diabetes research, advocacy, and educational programs.
Carmella Evans-Molina, MD, PhD, is the recipient of the 2023 Outstanding Scientific Achievement Award. The award honors research in diabetes that demonstrates particular independence of thought and originality. Dr. Evans-Molina will deliver the Outstanding Scientific Achievement Award Lecture on Monday at 10:15 a.m. PT in Halls GH. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.
Don't miss your chance to check out more than 1,400 posters featuring the latest research findings. The 83rd Scientific Sessions Poster Hall is open until 2:00 p.m. PT Monday. Poster presenters will be available for discussion during the final General Poster Session from 11:30 a.m. to 12:30 p.m. PT.
Stop by the ground level of the convention center before 2:00 p.m. PT Monday to see the latest products and services from exhibiting companies at this year's Scientific Sessions.
Mark A. Atkinson, PhD, is the recipient of the 2023 Harold Rifkin Award for Distinguished International Service in the Cause of Diabetes. The award honors individuals who have demonstrated outstanding research, evaluation, and care in diabetes performed from an international perspective with an international impact. Dr. Atkinson will be recognized during the National Scientific & Health Care Achievement Awards Presentation on Monday at 9:45 a.m. PT in Halls GH. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.
In a symposium beginning Monday at 8:00 a.m. PT in Room 28, Darren K. McGuire, MD, MHSc, will review sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists as part of an expert panel. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.
Read More
Presenter Anath Shalev, MD, shares insight into a symposium that begins Monday at 8:00 a.m. PT in Ballroom 20A-C. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.
Read More